Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thomas DL et al. – Targeting brain tumor stroma or increasing Ag shedding from tumor cells to enhance cross–presentation may improve the clinical success of T cell adoptive therapies.

Today in Hematology/Oncology...keeping you current

IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09

Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Clinical Cancer Research, 12/01/09

Today in Neurologic/Ophthalmic...keeping you current

Immunologic Paradox in the Diagnosis of Tuberculous Meningitis
Clinical and Vaccine Immunology, 12/02/09

SLAT/Def6 Plays a Critical Role in the Development of Th17 Cell-Mediated Experimental Autoimmune Encephalomyelitis
Journal of Immunology, 12/01/09

Efficient serum clearance of botulinum neurotoxin using a pool of small antitoxin binding agents
Infection and Immunity, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address